Global CAR T-Cell Therapy Agents Market Research Report 2024(Status and Outlook)
Report Overview:
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The Global CAR T-Cell Therapy Agents Market Size was estimated at USD 389.83 million in 2023 and is projected to reach USD 585.03 million by 2029, exhibiting a CAGR of 7.00% during the forecast period.
This report provides a deep insight into the global CAR T-Cell Therapy Agents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CAR T-Cell Therapy Agents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CAR T-Cell Therapy Agents market in any manner.
Global CAR T-Cell Therapy Agents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell Therapy Agents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The Global CAR T-Cell Therapy Agents Market Size was estimated at USD 389.83 million in 2023 and is projected to reach USD 585.03 million by 2029, exhibiting a CAGR of 7.00% during the forecast period.
This report provides a deep insight into the global CAR T-Cell Therapy Agents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CAR T-Cell Therapy Agents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CAR T-Cell Therapy Agents market in any manner.
Global CAR T-Cell Therapy Agents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the CAR T-Cell Therapy Agents Market
- Overview of the regional outlook of the CAR T-Cell Therapy Agents Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell Therapy Agents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of CAR T-Cell Therapy Agents
1.2 Key Market Segments
1.2.1 CAR T-Cell Therapy Agents Segment by Type
1.2.2 CAR T-Cell Therapy Agents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CAR T-CELL THERAPY AGENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CAR T-Cell Therapy Agents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global CAR T-Cell Therapy Agents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CAR T-CELL THERAPY AGENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global CAR T-Cell Therapy Agents Sales by Manufacturers (2019-2024)
3.2 Global CAR T-Cell Therapy Agents Revenue Market Share by Manufacturers (2019-2024)
3.3 CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CAR T-Cell Therapy Agents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers CAR T-Cell Therapy Agents Sales Sites, Area Served, Product Type
3.6 CAR T-Cell Therapy Agents Market Competitive Situation and Trends
3.6.1 CAR T-Cell Therapy Agents Market Concentration Rate
3.6.2 Global 5 and 10 Largest CAR T-Cell Therapy Agents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY AGENTS INDUSTRY CHAIN ANALYSIS
4.1 CAR T-Cell Therapy Agents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL THERAPY AGENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-Cell Therapy Agents Sales Market Share by Type (2019-2024)
6.3 Global CAR T-Cell Therapy Agents Market Size Market Share by Type (2019-2024)
6.4 Global CAR T-Cell Therapy Agents Price by Type (2019-2024)
7 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-Cell Therapy Agents Market Sales by Application (2019-2024)
7.3 Global CAR T-Cell Therapy Agents Market Size (M USD) by Application (2019-2024)
7.4 Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2019-2024)
8 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY REGION
8.1 Global CAR T-Cell Therapy Agents Sales by Region
8.1.1 Global CAR T-Cell Therapy Agents Sales by Region
8.1.2 Global CAR T-Cell Therapy Agents Sales Market Share by Region
8.2 North America
8.2.1 North America CAR T-Cell Therapy Agents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CAR T-Cell Therapy Agents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific CAR T-Cell Therapy Agents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CAR T-Cell Therapy Agents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CAR T-Cell Therapy Agents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis
9.1.1 Novartis CAR T-Cell Therapy Agents Basic Information
9.1.2 Novartis CAR T-Cell Therapy Agents Product Overview
9.1.3 Novartis CAR T-Cell Therapy Agents Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis CAR T-Cell Therapy Agents SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Gilead Sciences
9.2.1 Gilead Sciences CAR T-Cell Therapy Agents Basic Information
9.2.2 Gilead Sciences CAR T-Cell Therapy Agents Product Overview
9.2.3 Gilead Sciences CAR T-Cell Therapy Agents Product Market Performance
9.2.4 Gilead Sciences Business Overview
9.2.5 Gilead Sciences CAR T-Cell Therapy Agents SWOT Analysis
9.2.6 Gilead Sciences Recent Developments
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb CAR T-Cell Therapy Agents Basic Information
9.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Overview
9.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Market Performance
9.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Agents SWOT Analysis
9.3.5 Bristol-Myers Squibb Business Overview
9.3.6 Bristol-Myers Squibb Recent Developments
9.4 J and J
9.4.1 J and J CAR T-Cell Therapy Agents Basic Information
9.4.2 J and J CAR T-Cell Therapy Agents Product Overview
9.4.3 J and J CAR T-Cell Therapy Agents Product Market Performance
9.4.4 J and J Business Overview
9.4.5 J and J Recent Developments
9.5 JW Therapeutics
9.5.1 JW Therapeutics CAR T-Cell Therapy Agents Basic Information
9.5.2 JW Therapeutics CAR T-Cell Therapy Agents Product Overview
9.5.3 JW Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.5.4 JW Therapeutics Business Overview
9.5.5 JW Therapeutics Recent Developments
9.6 FOSUNKite
9.6.1 FOSUNKite CAR T-Cell Therapy Agents Basic Information
9.6.2 FOSUNKite CAR T-Cell Therapy Agents Product Overview
9.6.3 FOSUNKite CAR T-Cell Therapy Agents Product Market Performance
9.6.4 FOSUNKite Business Overview
9.6.5 FOSUNKite Recent Developments
9.7 CARsgen Therapeutics (Pipeline)
9.7.1 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Basic Information
9.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Overview
9.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Market Performance
9.7.4 CARsgen Therapeutics (Pipeline) Business Overview
9.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
9.8 CARsgen Therapeutics
9.8.1 CARsgen Therapeutics CAR T-Cell Therapy Agents Basic Information
9.8.2 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Overview
9.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.8.4 CARsgen Therapeutics Business Overview
9.8.5 CARsgen Therapeutics Recent Developments
9.9 Autolus Therapeutics
9.9.1 Autolus Therapeutics CAR T-Cell Therapy Agents Basic Information
9.9.2 Autolus Therapeutics CAR T-Cell Therapy Agents Product Overview
9.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.9.4 Autolus Therapeutics Business Overview
9.9.5 Autolus Therapeutics Recent Developments
9.10 Sorrento Therapeutics
9.10.1 Sorrento Therapeutics CAR T-Cell Therapy Agents Basic Information
9.10.2 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Overview
9.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.10.4 Sorrento Therapeutics Business Overview
9.10.5 Sorrento Therapeutics Recent Developments
9.11 Mustang Bio
9.11.1 Mustang Bio CAR T-Cell Therapy Agents Basic Information
9.11.2 Mustang Bio CAR T-Cell Therapy Agents Product Overview
9.11.3 Mustang Bio CAR T-Cell Therapy Agents Product Market Performance
9.11.4 Mustang Bio Business Overview
9.11.5 Mustang Bio Recent Developments
9.12 Bluebird Bio
9.12.1 Bluebird Bio CAR T-Cell Therapy Agents Basic Information
9.12.2 Bluebird Bio CAR T-Cell Therapy Agents Product Overview
9.12.3 Bluebird Bio CAR T-Cell Therapy Agents Product Market Performance
9.12.4 Bluebird Bio Business Overview
9.12.5 Bluebird Bio Recent Developments
9.13 Cellectis
9.13.1 Cellectis CAR T-Cell Therapy Agents Basic Information
9.13.2 Cellectis CAR T-Cell Therapy Agents Product Overview
9.13.3 Cellectis CAR T-Cell Therapy Agents Product Market Performance
9.13.4 Cellectis Business Overview
9.13.5 Cellectis Recent Developments
9.14 Allogene Therapeutics
9.14.1 Allogene Therapeutics CAR T-Cell Therapy Agents Basic Information
9.14.2 Allogene Therapeutics CAR T-Cell Therapy Agents Product Overview
9.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.14.4 Allogene Therapeutics Business Overview
9.14.5 Allogene Therapeutics Recent Developments
9.15 Celyad
9.15.1 Celyad CAR T-Cell Therapy Agents Basic Information
9.15.2 Celyad CAR T-Cell Therapy Agents Product Overview
9.15.3 Celyad CAR T-Cell Therapy Agents Product Market Performance
9.15.4 Celyad Business Overview
9.15.5 Celyad Recent Developments
10 CAR T-CELL THERAPY AGENTS MARKET FORECAST BY REGION
10.1 Global CAR T-Cell Therapy Agents Market Size Forecast
10.2 Global CAR T-Cell Therapy Agents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CAR T-Cell Therapy Agents Market Size Forecast by Country
10.2.3 Asia Pacific CAR T-Cell Therapy Agents Market Size Forecast by Region
10.2.4 South America CAR T-Cell Therapy Agents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of CAR T-Cell Therapy Agents by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global CAR T-Cell Therapy Agents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of CAR T-Cell Therapy Agents by Type (2025-2030)
11.1.2 Global CAR T-Cell Therapy Agents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of CAR T-Cell Therapy Agents by Type (2025-2030)
11.2 Global CAR T-Cell Therapy Agents Market Forecast by Application (2025-2030)
11.2.1 Global CAR T-Cell Therapy Agents Sales (Kilotons) Forecast by Application
11.2.2 Global CAR T-Cell Therapy Agents Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of CAR T-Cell Therapy Agents
1.2 Key Market Segments
1.2.1 CAR T-Cell Therapy Agents Segment by Type
1.2.2 CAR T-Cell Therapy Agents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CAR T-CELL THERAPY AGENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CAR T-Cell Therapy Agents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global CAR T-Cell Therapy Agents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CAR T-CELL THERAPY AGENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global CAR T-Cell Therapy Agents Sales by Manufacturers (2019-2024)
3.2 Global CAR T-Cell Therapy Agents Revenue Market Share by Manufacturers (2019-2024)
3.3 CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CAR T-Cell Therapy Agents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers CAR T-Cell Therapy Agents Sales Sites, Area Served, Product Type
3.6 CAR T-Cell Therapy Agents Market Competitive Situation and Trends
3.6.1 CAR T-Cell Therapy Agents Market Concentration Rate
3.6.2 Global 5 and 10 Largest CAR T-Cell Therapy Agents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY AGENTS INDUSTRY CHAIN ANALYSIS
4.1 CAR T-Cell Therapy Agents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL THERAPY AGENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-Cell Therapy Agents Sales Market Share by Type (2019-2024)
6.3 Global CAR T-Cell Therapy Agents Market Size Market Share by Type (2019-2024)
6.4 Global CAR T-Cell Therapy Agents Price by Type (2019-2024)
7 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-Cell Therapy Agents Market Sales by Application (2019-2024)
7.3 Global CAR T-Cell Therapy Agents Market Size (M USD) by Application (2019-2024)
7.4 Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2019-2024)
8 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY REGION
8.1 Global CAR T-Cell Therapy Agents Sales by Region
8.1.1 Global CAR T-Cell Therapy Agents Sales by Region
8.1.2 Global CAR T-Cell Therapy Agents Sales Market Share by Region
8.2 North America
8.2.1 North America CAR T-Cell Therapy Agents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CAR T-Cell Therapy Agents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific CAR T-Cell Therapy Agents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CAR T-Cell Therapy Agents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CAR T-Cell Therapy Agents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis
9.1.1 Novartis CAR T-Cell Therapy Agents Basic Information
9.1.2 Novartis CAR T-Cell Therapy Agents Product Overview
9.1.3 Novartis CAR T-Cell Therapy Agents Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis CAR T-Cell Therapy Agents SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Gilead Sciences
9.2.1 Gilead Sciences CAR T-Cell Therapy Agents Basic Information
9.2.2 Gilead Sciences CAR T-Cell Therapy Agents Product Overview
9.2.3 Gilead Sciences CAR T-Cell Therapy Agents Product Market Performance
9.2.4 Gilead Sciences Business Overview
9.2.5 Gilead Sciences CAR T-Cell Therapy Agents SWOT Analysis
9.2.6 Gilead Sciences Recent Developments
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb CAR T-Cell Therapy Agents Basic Information
9.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Overview
9.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Market Performance
9.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Agents SWOT Analysis
9.3.5 Bristol-Myers Squibb Business Overview
9.3.6 Bristol-Myers Squibb Recent Developments
9.4 J and J
9.4.1 J and J CAR T-Cell Therapy Agents Basic Information
9.4.2 J and J CAR T-Cell Therapy Agents Product Overview
9.4.3 J and J CAR T-Cell Therapy Agents Product Market Performance
9.4.4 J and J Business Overview
9.4.5 J and J Recent Developments
9.5 JW Therapeutics
9.5.1 JW Therapeutics CAR T-Cell Therapy Agents Basic Information
9.5.2 JW Therapeutics CAR T-Cell Therapy Agents Product Overview
9.5.3 JW Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.5.4 JW Therapeutics Business Overview
9.5.5 JW Therapeutics Recent Developments
9.6 FOSUNKite
9.6.1 FOSUNKite CAR T-Cell Therapy Agents Basic Information
9.6.2 FOSUNKite CAR T-Cell Therapy Agents Product Overview
9.6.3 FOSUNKite CAR T-Cell Therapy Agents Product Market Performance
9.6.4 FOSUNKite Business Overview
9.6.5 FOSUNKite Recent Developments
9.7 CARsgen Therapeutics (Pipeline)
9.7.1 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Basic Information
9.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Overview
9.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Market Performance
9.7.4 CARsgen Therapeutics (Pipeline) Business Overview
9.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
9.8 CARsgen Therapeutics
9.8.1 CARsgen Therapeutics CAR T-Cell Therapy Agents Basic Information
9.8.2 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Overview
9.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.8.4 CARsgen Therapeutics Business Overview
9.8.5 CARsgen Therapeutics Recent Developments
9.9 Autolus Therapeutics
9.9.1 Autolus Therapeutics CAR T-Cell Therapy Agents Basic Information
9.9.2 Autolus Therapeutics CAR T-Cell Therapy Agents Product Overview
9.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.9.4 Autolus Therapeutics Business Overview
9.9.5 Autolus Therapeutics Recent Developments
9.10 Sorrento Therapeutics
9.10.1 Sorrento Therapeutics CAR T-Cell Therapy Agents Basic Information
9.10.2 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Overview
9.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.10.4 Sorrento Therapeutics Business Overview
9.10.5 Sorrento Therapeutics Recent Developments
9.11 Mustang Bio
9.11.1 Mustang Bio CAR T-Cell Therapy Agents Basic Information
9.11.2 Mustang Bio CAR T-Cell Therapy Agents Product Overview
9.11.3 Mustang Bio CAR T-Cell Therapy Agents Product Market Performance
9.11.4 Mustang Bio Business Overview
9.11.5 Mustang Bio Recent Developments
9.12 Bluebird Bio
9.12.1 Bluebird Bio CAR T-Cell Therapy Agents Basic Information
9.12.2 Bluebird Bio CAR T-Cell Therapy Agents Product Overview
9.12.3 Bluebird Bio CAR T-Cell Therapy Agents Product Market Performance
9.12.4 Bluebird Bio Business Overview
9.12.5 Bluebird Bio Recent Developments
9.13 Cellectis
9.13.1 Cellectis CAR T-Cell Therapy Agents Basic Information
9.13.2 Cellectis CAR T-Cell Therapy Agents Product Overview
9.13.3 Cellectis CAR T-Cell Therapy Agents Product Market Performance
9.13.4 Cellectis Business Overview
9.13.5 Cellectis Recent Developments
9.14 Allogene Therapeutics
9.14.1 Allogene Therapeutics CAR T-Cell Therapy Agents Basic Information
9.14.2 Allogene Therapeutics CAR T-Cell Therapy Agents Product Overview
9.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Product Market Performance
9.14.4 Allogene Therapeutics Business Overview
9.14.5 Allogene Therapeutics Recent Developments
9.15 Celyad
9.15.1 Celyad CAR T-Cell Therapy Agents Basic Information
9.15.2 Celyad CAR T-Cell Therapy Agents Product Overview
9.15.3 Celyad CAR T-Cell Therapy Agents Product Market Performance
9.15.4 Celyad Business Overview
9.15.5 Celyad Recent Developments
10 CAR T-CELL THERAPY AGENTS MARKET FORECAST BY REGION
10.1 Global CAR T-Cell Therapy Agents Market Size Forecast
10.2 Global CAR T-Cell Therapy Agents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CAR T-Cell Therapy Agents Market Size Forecast by Country
10.2.3 Asia Pacific CAR T-Cell Therapy Agents Market Size Forecast by Region
10.2.4 South America CAR T-Cell Therapy Agents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of CAR T-Cell Therapy Agents by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global CAR T-Cell Therapy Agents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of CAR T-Cell Therapy Agents by Type (2025-2030)
11.1.2 Global CAR T-Cell Therapy Agents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of CAR T-Cell Therapy Agents by Type (2025-2030)
11.2 Global CAR T-Cell Therapy Agents Market Forecast by Application (2025-2030)
11.2.1 Global CAR T-Cell Therapy Agents Sales (Kilotons) Forecast by Application
11.2.2 Global CAR T-Cell Therapy Agents Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CAR T-Cell Therapy Agents Market Size Comparison by Region (M USD)
Table 5. Global CAR T-Cell Therapy Agents Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global CAR T-Cell Therapy Agents Sales Market Share by Manufacturers (2019-2024)
Table 7. Global CAR T-Cell Therapy Agents Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global CAR T-Cell Therapy Agents Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2022)
Table 10. Global Market CAR T-Cell Therapy Agents Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers CAR T-Cell Therapy Agents Sales Sites and Area Served
Table 12. Manufacturers CAR T-Cell Therapy Agents Product Type
Table 13. Global CAR T-Cell Therapy Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of CAR T-Cell Therapy Agents
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-Cell Therapy Agents Market Challenges
Table 22. Global CAR T-Cell Therapy Agents Sales by Type (Kilotons)
Table 23. Global CAR T-Cell Therapy Agents Market Size by Type (M USD)
Table 24. Global CAR T-Cell Therapy Agents Sales (Kilotons) by Type (2019-2024)
Table 25. Global CAR T-Cell Therapy Agents Sales Market Share by Type (2019-2024)
Table 26. Global CAR T-Cell Therapy Agents Market Size (M USD) by Type (2019-2024)
Table 27. Global CAR T-Cell Therapy Agents Market Size Share by Type (2019-2024)
Table 28. Global CAR T-Cell Therapy Agents Price (USD/Ton) by Type (2019-2024)
Table 29. Global CAR T-Cell Therapy Agents Sales (Kilotons) by Application
Table 30. Global CAR T-Cell Therapy Agents Market Size by Application
Table 31. Global CAR T-Cell Therapy Agents Sales by Application (2019-2024) & (Kilotons)
Table 32. Global CAR T-Cell Therapy Agents Sales Market Share by Application (2019-2024)
Table 33. Global CAR T-Cell Therapy Agents Sales by Application (2019-2024) & (M USD)
Table 34. Global CAR T-Cell Therapy Agents Market Share by Application (2019-2024)
Table 35. Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2019-2024)
Table 36. Global CAR T-Cell Therapy Agents Sales by Region (2019-2024) & (Kilotons)
Table 37. Global CAR T-Cell Therapy Agents Sales Market Share by Region (2019-2024)
Table 38. North America CAR T-Cell Therapy Agents Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe CAR T-Cell Therapy Agents Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific CAR T-Cell Therapy Agents Sales by Region (2019-2024) & (Kilotons)
Table 41. South America CAR T-Cell Therapy Agents Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa CAR T-Cell Therapy Agents Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis CAR T-Cell Therapy Agents Basic Information
Table 44. Novartis CAR T-Cell Therapy Agents Product Overview
Table 45. Novartis CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis CAR T-Cell Therapy Agents SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Gilead Sciences CAR T-Cell Therapy Agents Basic Information
Table 50. Gilead Sciences CAR T-Cell Therapy Agents Product Overview
Table 51. Gilead Sciences CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences CAR T-Cell Therapy Agents SWOT Analysis
Table 54. Gilead Sciences Recent Developments
Table 55. Bristol-Myers Squibb CAR T-Cell Therapy Agents Basic Information
Table 56. Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Overview
Table 57. Bristol-Myers Squibb CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bristol-Myers Squibb CAR T-Cell Therapy Agents SWOT Analysis
Table 59. Bristol-Myers Squibb Business Overview
Table 60. Bristol-Myers Squibb Recent Developments
Table 61. J and J CAR T-Cell Therapy Agents Basic Information
Table 62. J and J CAR T-Cell Therapy Agents Product Overview
Table 63. J and J CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. J and J Business Overview
Table 65. J and J Recent Developments
Table 66. JW Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 67. JW Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 68. JW Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. JW Therapeutics Business Overview
Table 70. JW Therapeutics Recent Developments
Table 71. FOSUNKite CAR T-Cell Therapy Agents Basic Information
Table 72. FOSUNKite CAR T-Cell Therapy Agents Product Overview
Table 73. FOSUNKite CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. FOSUNKite Business Overview
Table 75. FOSUNKite Recent Developments
Table 76. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Basic Information
Table 77. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Overview
Table 78. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. CARsgen Therapeutics (Pipeline) Business Overview
Table 80. CARsgen Therapeutics (Pipeline) Recent Developments
Table 81. CARsgen Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 82. CARsgen Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 83. CARsgen Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CARsgen Therapeutics Business Overview
Table 85. CARsgen Therapeutics Recent Developments
Table 86. Autolus Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 87. Autolus Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 88. Autolus Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Autolus Therapeutics Business Overview
Table 90. Autolus Therapeutics Recent Developments
Table 91. Sorrento Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 92. Sorrento Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 93. Sorrento Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Sorrento Therapeutics Business Overview
Table 95. Sorrento Therapeutics Recent Developments
Table 96. Mustang Bio CAR T-Cell Therapy Agents Basic Information
Table 97. Mustang Bio CAR T-Cell Therapy Agents Product Overview
Table 98. Mustang Bio CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mustang Bio Business Overview
Table 100. Mustang Bio Recent Developments
Table 101. Bluebird Bio CAR T-Cell Therapy Agents Basic Information
Table 102. Bluebird Bio CAR T-Cell Therapy Agents Product Overview
Table 103. Bluebird Bio CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Bluebird Bio Business Overview
Table 105. Bluebird Bio Recent Developments
Table 106. Cellectis CAR T-Cell Therapy Agents Basic Information
Table 107. Cellectis CAR T-Cell Therapy Agents Product Overview
Table 108. Cellectis CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Cellectis Business Overview
Table 110. Cellectis Recent Developments
Table 111. Allogene Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 112. Allogene Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 113. Allogene Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Allogene Therapeutics Business Overview
Table 115. Allogene Therapeutics Recent Developments
Table 116. Celyad CAR T-Cell Therapy Agents Basic Information
Table 117. Celyad CAR T-Cell Therapy Agents Product Overview
Table 118. Celyad CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Celyad Business Overview
Table 120. Celyad Recent Developments
Table 121. Global CAR T-Cell Therapy Agents Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global CAR T-Cell Therapy Agents Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America CAR T-Cell Therapy Agents Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America CAR T-Cell Therapy Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe CAR T-Cell Therapy Agents Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe CAR T-Cell Therapy Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific CAR T-Cell Therapy Agents Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific CAR T-Cell Therapy Agents Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America CAR T-Cell Therapy Agents Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America CAR T-Cell Therapy Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa CAR T-Cell Therapy Agents Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa CAR T-Cell Therapy Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global CAR T-Cell Therapy Agents Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global CAR T-Cell Therapy Agents Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global CAR T-Cell Therapy Agents Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global CAR T-Cell Therapy Agents Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global CAR T-Cell Therapy Agents Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CAR T-Cell Therapy Agents Market Size Comparison by Region (M USD)
Table 5. Global CAR T-Cell Therapy Agents Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global CAR T-Cell Therapy Agents Sales Market Share by Manufacturers (2019-2024)
Table 7. Global CAR T-Cell Therapy Agents Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global CAR T-Cell Therapy Agents Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2022)
Table 10. Global Market CAR T-Cell Therapy Agents Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers CAR T-Cell Therapy Agents Sales Sites and Area Served
Table 12. Manufacturers CAR T-Cell Therapy Agents Product Type
Table 13. Global CAR T-Cell Therapy Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of CAR T-Cell Therapy Agents
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-Cell Therapy Agents Market Challenges
Table 22. Global CAR T-Cell Therapy Agents Sales by Type (Kilotons)
Table 23. Global CAR T-Cell Therapy Agents Market Size by Type (M USD)
Table 24. Global CAR T-Cell Therapy Agents Sales (Kilotons) by Type (2019-2024)
Table 25. Global CAR T-Cell Therapy Agents Sales Market Share by Type (2019-2024)
Table 26. Global CAR T-Cell Therapy Agents Market Size (M USD) by Type (2019-2024)
Table 27. Global CAR T-Cell Therapy Agents Market Size Share by Type (2019-2024)
Table 28. Global CAR T-Cell Therapy Agents Price (USD/Ton) by Type (2019-2024)
Table 29. Global CAR T-Cell Therapy Agents Sales (Kilotons) by Application
Table 30. Global CAR T-Cell Therapy Agents Market Size by Application
Table 31. Global CAR T-Cell Therapy Agents Sales by Application (2019-2024) & (Kilotons)
Table 32. Global CAR T-Cell Therapy Agents Sales Market Share by Application (2019-2024)
Table 33. Global CAR T-Cell Therapy Agents Sales by Application (2019-2024) & (M USD)
Table 34. Global CAR T-Cell Therapy Agents Market Share by Application (2019-2024)
Table 35. Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2019-2024)
Table 36. Global CAR T-Cell Therapy Agents Sales by Region (2019-2024) & (Kilotons)
Table 37. Global CAR T-Cell Therapy Agents Sales Market Share by Region (2019-2024)
Table 38. North America CAR T-Cell Therapy Agents Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe CAR T-Cell Therapy Agents Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific CAR T-Cell Therapy Agents Sales by Region (2019-2024) & (Kilotons)
Table 41. South America CAR T-Cell Therapy Agents Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa CAR T-Cell Therapy Agents Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis CAR T-Cell Therapy Agents Basic Information
Table 44. Novartis CAR T-Cell Therapy Agents Product Overview
Table 45. Novartis CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis CAR T-Cell Therapy Agents SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Gilead Sciences CAR T-Cell Therapy Agents Basic Information
Table 50. Gilead Sciences CAR T-Cell Therapy Agents Product Overview
Table 51. Gilead Sciences CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences CAR T-Cell Therapy Agents SWOT Analysis
Table 54. Gilead Sciences Recent Developments
Table 55. Bristol-Myers Squibb CAR T-Cell Therapy Agents Basic Information
Table 56. Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Overview
Table 57. Bristol-Myers Squibb CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bristol-Myers Squibb CAR T-Cell Therapy Agents SWOT Analysis
Table 59. Bristol-Myers Squibb Business Overview
Table 60. Bristol-Myers Squibb Recent Developments
Table 61. J and J CAR T-Cell Therapy Agents Basic Information
Table 62. J and J CAR T-Cell Therapy Agents Product Overview
Table 63. J and J CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. J and J Business Overview
Table 65. J and J Recent Developments
Table 66. JW Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 67. JW Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 68. JW Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. JW Therapeutics Business Overview
Table 70. JW Therapeutics Recent Developments
Table 71. FOSUNKite CAR T-Cell Therapy Agents Basic Information
Table 72. FOSUNKite CAR T-Cell Therapy Agents Product Overview
Table 73. FOSUNKite CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. FOSUNKite Business Overview
Table 75. FOSUNKite Recent Developments
Table 76. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Basic Information
Table 77. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Overview
Table 78. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. CARsgen Therapeutics (Pipeline) Business Overview
Table 80. CARsgen Therapeutics (Pipeline) Recent Developments
Table 81. CARsgen Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 82. CARsgen Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 83. CARsgen Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CARsgen Therapeutics Business Overview
Table 85. CARsgen Therapeutics Recent Developments
Table 86. Autolus Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 87. Autolus Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 88. Autolus Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Autolus Therapeutics Business Overview
Table 90. Autolus Therapeutics Recent Developments
Table 91. Sorrento Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 92. Sorrento Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 93. Sorrento Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Sorrento Therapeutics Business Overview
Table 95. Sorrento Therapeutics Recent Developments
Table 96. Mustang Bio CAR T-Cell Therapy Agents Basic Information
Table 97. Mustang Bio CAR T-Cell Therapy Agents Product Overview
Table 98. Mustang Bio CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mustang Bio Business Overview
Table 100. Mustang Bio Recent Developments
Table 101. Bluebird Bio CAR T-Cell Therapy Agents Basic Information
Table 102. Bluebird Bio CAR T-Cell Therapy Agents Product Overview
Table 103. Bluebird Bio CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Bluebird Bio Business Overview
Table 105. Bluebird Bio Recent Developments
Table 106. Cellectis CAR T-Cell Therapy Agents Basic Information
Table 107. Cellectis CAR T-Cell Therapy Agents Product Overview
Table 108. Cellectis CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Cellectis Business Overview
Table 110. Cellectis Recent Developments
Table 111. Allogene Therapeutics CAR T-Cell Therapy Agents Basic Information
Table 112. Allogene Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 113. Allogene Therapeutics CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Allogene Therapeutics Business Overview
Table 115. Allogene Therapeutics Recent Developments
Table 116. Celyad CAR T-Cell Therapy Agents Basic Information
Table 117. Celyad CAR T-Cell Therapy Agents Product Overview
Table 118. Celyad CAR T-Cell Therapy Agents Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Celyad Business Overview
Table 120. Celyad Recent Developments
Table 121. Global CAR T-Cell Therapy Agents Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global CAR T-Cell Therapy Agents Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America CAR T-Cell Therapy Agents Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America CAR T-Cell Therapy Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe CAR T-Cell Therapy Agents Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe CAR T-Cell Therapy Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific CAR T-Cell Therapy Agents Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific CAR T-Cell Therapy Agents Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America CAR T-Cell Therapy Agents Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America CAR T-Cell Therapy Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa CAR T-Cell Therapy Agents Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa CAR T-Cell Therapy Agents Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global CAR T-Cell Therapy Agents Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global CAR T-Cell Therapy Agents Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global CAR T-Cell Therapy Agents Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global CAR T-Cell Therapy Agents Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global CAR T-Cell Therapy Agents Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of CAR T-Cell Therapy Agents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-Cell Therapy Agents Market Size (M USD), 2019-2030
Figure 5. Global CAR T-Cell Therapy Agents Market Size (M USD) (2019-2030)
Figure 6. Global CAR T-Cell Therapy Agents Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-Cell Therapy Agents Market Size by Country (M USD)
Figure 11. CAR T-Cell Therapy Agents Sales Share by Manufacturers in 2023
Figure 12. Global CAR T-Cell Therapy Agents Revenue Share by Manufacturers in 2023
Figure 13. CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market CAR T-Cell Therapy Agents Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by CAR T-Cell Therapy Agents Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global CAR T-Cell Therapy Agents Market Share by Type
Figure 18. Sales Market Share of CAR T-Cell Therapy Agents by Type (2019-2024)
Figure 19. Sales Market Share of CAR T-Cell Therapy Agents by Type in 2023
Figure 20. Market Size Share of CAR T-Cell Therapy Agents by Type (2019-2024)
Figure 21. Market Size Market Share of CAR T-Cell Therapy Agents by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global CAR T-Cell Therapy Agents Market Share by Application
Figure 24. Global CAR T-Cell Therapy Agents Sales Market Share by Application (2019-2024)
Figure 25. Global CAR T-Cell Therapy Agents Sales Market Share by Application in 2023
Figure 26. Global CAR T-Cell Therapy Agents Market Share by Application (2019-2024)
Figure 27. Global CAR T-Cell Therapy Agents Market Share by Application in 2023
Figure 28. Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2019-2024)
Figure 29. Global CAR T-Cell Therapy Agents Sales Market Share by Region (2019-2024)
Figure 30. North America CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America CAR T-Cell Therapy Agents Sales Market Share by Country in 2023
Figure 32. U.S. CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada CAR T-Cell Therapy Agents Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico CAR T-Cell Therapy Agents Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe CAR T-Cell Therapy Agents Sales Market Share by Country in 2023
Figure 37. Germany CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific CAR T-Cell Therapy Agents Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific CAR T-Cell Therapy Agents Sales Market Share by Region in 2023
Figure 44. China CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America CAR T-Cell Therapy Agents Sales and Growth Rate (Kilotons)
Figure 50. South America CAR T-Cell Therapy Agents Sales Market Share by Country in 2023
Figure 51. Brazil CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa CAR T-Cell Therapy Agents Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa CAR T-Cell Therapy Agents Sales Market Share by Region in 2023
Figure 56. Saudi Arabia CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global CAR T-Cell Therapy Agents Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global CAR T-Cell Therapy Agents Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global CAR T-Cell Therapy Agents Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global CAR T-Cell Therapy Agents Market Share Forecast by Type (2025-2030)
Figure 65. Global CAR T-Cell Therapy Agents Sales Forecast by Application (2025-2030)
Figure 66. Global CAR T-Cell Therapy Agents Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of CAR T-Cell Therapy Agents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-Cell Therapy Agents Market Size (M USD), 2019-2030
Figure 5. Global CAR T-Cell Therapy Agents Market Size (M USD) (2019-2030)
Figure 6. Global CAR T-Cell Therapy Agents Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-Cell Therapy Agents Market Size by Country (M USD)
Figure 11. CAR T-Cell Therapy Agents Sales Share by Manufacturers in 2023
Figure 12. Global CAR T-Cell Therapy Agents Revenue Share by Manufacturers in 2023
Figure 13. CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market CAR T-Cell Therapy Agents Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by CAR T-Cell Therapy Agents Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global CAR T-Cell Therapy Agents Market Share by Type
Figure 18. Sales Market Share of CAR T-Cell Therapy Agents by Type (2019-2024)
Figure 19. Sales Market Share of CAR T-Cell Therapy Agents by Type in 2023
Figure 20. Market Size Share of CAR T-Cell Therapy Agents by Type (2019-2024)
Figure 21. Market Size Market Share of CAR T-Cell Therapy Agents by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global CAR T-Cell Therapy Agents Market Share by Application
Figure 24. Global CAR T-Cell Therapy Agents Sales Market Share by Application (2019-2024)
Figure 25. Global CAR T-Cell Therapy Agents Sales Market Share by Application in 2023
Figure 26. Global CAR T-Cell Therapy Agents Market Share by Application (2019-2024)
Figure 27. Global CAR T-Cell Therapy Agents Market Share by Application in 2023
Figure 28. Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2019-2024)
Figure 29. Global CAR T-Cell Therapy Agents Sales Market Share by Region (2019-2024)
Figure 30. North America CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America CAR T-Cell Therapy Agents Sales Market Share by Country in 2023
Figure 32. U.S. CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada CAR T-Cell Therapy Agents Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico CAR T-Cell Therapy Agents Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe CAR T-Cell Therapy Agents Sales Market Share by Country in 2023
Figure 37. Germany CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific CAR T-Cell Therapy Agents Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific CAR T-Cell Therapy Agents Sales Market Share by Region in 2023
Figure 44. China CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America CAR T-Cell Therapy Agents Sales and Growth Rate (Kilotons)
Figure 50. South America CAR T-Cell Therapy Agents Sales Market Share by Country in 2023
Figure 51. Brazil CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa CAR T-Cell Therapy Agents Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa CAR T-Cell Therapy Agents Sales Market Share by Region in 2023
Figure 56. Saudi Arabia CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa CAR T-Cell Therapy Agents Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global CAR T-Cell Therapy Agents Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global CAR T-Cell Therapy Agents Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global CAR T-Cell Therapy Agents Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global CAR T-Cell Therapy Agents Market Share Forecast by Type (2025-2030)
Figure 65. Global CAR T-Cell Therapy Agents Sales Forecast by Application (2025-2030)
Figure 66. Global CAR T-Cell Therapy Agents Market Share Forecast by Application (2025-2030)
